5-(Perylen-3-yl)ethynyl-arabino-uridine (aUY11), an arabino-based rigid amphipathic fusion inhibitor, targets virion envelope lipids to inhibit fusion of influenza virus, hepatitis C virus, and other enveloped viruses
about
Entry inhibitors: New advances in HCV treatmentHepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1.Broad-spectrum antivirals against viral fusion.Importance of the hexagonal lipid phase in biological membrane organization.Evaluation of PD 404,182 as an anti-HIV and anti-herpes simplex virus microbicide.The rigid amphipathic fusion inhibitor dUY11 acts through photosensitization of viruses.How hepatitis C virus invades hepatocytes: the mystery of viral entryNanomedicine for Infectious Disease Applications: Innovation towards Broad-Spectrum Treatment of Viral Infections.Clinically Approved Ion Channel Inhibitors Close Gates for Hepatitis C Virus and Open Doors for Drug Repurposing in Infectious Viral Diseases.A comparative review of viral entry and attachment during large and giant dsDNA virus infections.A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans.The influenza fusion peptide promotes lipid polar head intrusion through hydrogen bonding with phosphates and N-terminal membrane insertion depth.Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses.
P2860
Q26770817-355A99E9-FC70-4FC5-A8AB-178C11747F87Q30386551-5D038008-34AD-4B28-B7FC-16B882F4993AQ35739094-96D4C990-221E-4167-9E6F-7757256625D5Q36010083-7C3B4295-433E-48E4-B9C1-4EDA7E7BC6BFQ37358928-48D7A02F-296A-434F-BC33-303D65CBB7A8Q37544670-0C0C8696-C3A0-4BF7-9212-357BC20B026FQ37547261-806F1A5D-947F-40E3-8738-52CB0187A9D5Q37682499-FFFE2C50-4840-470D-AA44-0B5E8D4F0FBBQ38628767-609E15FA-1FD8-42AE-902B-5EA57A97F7FDQ38997064-A3529A6C-5F5E-460C-BD6D-4EB33CD0ED36Q40060063-C40E5998-2935-49C9-9B6B-41E43207132CQ42220929-62455B53-5CEB-4716-B37C-F06A67742406Q42229093-FE5A1DC9-C3D4-415B-968E-9B87B1E2DE35Q54256710-980A86F6-05EB-42CC-9A35-9F3C2B42AF15
P2860
5-(Perylen-3-yl)ethynyl-arabino-uridine (aUY11), an arabino-based rigid amphipathic fusion inhibitor, targets virion envelope lipids to inhibit fusion of influenza virus, hepatitis C virus, and other enveloped viruses
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
5-(Perylen-3-yl)ethynyl-arabin ...... s, and other enveloped viruses
@en
5-(Perylen-3-yl)ethynyl-arabin ...... , and other enveloped viruses.
@nl
type
label
5-(Perylen-3-yl)ethynyl-arabin ...... s, and other enveloped viruses
@en
5-(Perylen-3-yl)ethynyl-arabin ...... , and other enveloped viruses.
@nl
prefLabel
5-(Perylen-3-yl)ethynyl-arabin ...... s, and other enveloped viruses
@en
5-(Perylen-3-yl)ethynyl-arabin ...... , and other enveloped viruses.
@nl
P2093
P2860
P356
P1433
P1476
5-(Perylen-3-yl)ethynyl-arabin ...... s, and other enveloped viruses
@en
P2093
Luis M Schang
Raquel F Epand
Richard M Epand
Vladimir A Korshun
P2860
P304
P356
10.1128/JVI.02882-12
P407
P577
2013-01-02T00:00:00Z